Junjie Liu

Dr. Junjie Liu

Harbin Sport University, Harbin, Heilongjiang, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
WYWenyan Yu
Wenyan Yu
NYNa Yin
Na Yin
YYYue Yang
Yue Yang
CXCuiping Xuan
Cuiping Xuan
XLXin Liu
Xin Liu
JSJinjin Shi
Jinjin Shi

5 March 2024 in Advanced Science
Verified
Journal Article
Open access
NYNa Yin
Na Yin
WWWenya Wang
Wenya Wang
FPFei Pei
Fei Pei
YZYuzhen Zhao
Yuzhen Zhao
CLChanghua Liu
Changhua Liu
JLJunjie Liu
Junjie Liu
Precise and efficient regulation of microglia is vital for ischemic stroke therapy and prognosis. The infiltration of neutrophils into the brain provides opportunities for regulatory drugs across the blood–brain barrier, while hindered by neutrophil extracellular traps (NETs) and targeted delivery of intracerebral drugs to microglia. This study reports an efficient neutrophil hijacking nanoplatform (referred to as APTS) for targeted A151 (a telomerase repeat sequence) delivery to microglia without the generation of NETs. In the middle cerebral artery occlusion (MCAO) mouse model, the delivery efficiency to ischemic stroke tissues increases by fourfold. APTS dramatically reduces the formation of NETs by 2.2‐fold via reprogramming NETosis to apoptosis in neutrophils via a reactive oxygen species scavenging‐mediated citrullinated histone 3 inhibition pathway. Noteworthy, A151 within neutrophils is repackaged into apoptotic bodies following the death pattern reprogramming, which, when engulfed by microglia, polarizes microglia to an anti‐inflammatory M2 phenotype. After four times treatment, the cerebral infarction area in the APTS group decreases by 5.1‐fold. Thus, APTS provides a feasible, efficient, and practical drug delivery approach for reshaping the immune microenvironment and treating brain disorders in the central nervous system.

10 February 2023 in Chinese Chemical Letters
Verified
Journal Article
Closed access
WYWenyan Yu
Wenyan Yu
EGEnpeng Gong
Enpeng Gong
BLBingbing Liu
Bingbing Liu
LZLei Zhou
Lei Zhou
CCChengyuan Che
Chengyuan Che
JSJinjin Shi
Jinjin Shi

3 February 2023 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
WYWenyan Yu
Wenyan Yu
BLBingbing Liu
Bingbing Liu
LZLei Zhou
Lei Zhou
EGEnpeng Gong
Enpeng Gong
CCChengyuan Che
Chengyuan Che
JSJinjin Shi
Jinjin Shi

15 April 2022 in Medicine in Drug Discovery
Verified
Journal Article
Open access
YYYue Yang
Yue Yang
NYNa Yin
Na Yin
ZGZichen Gu
Zichen Gu
YZYuzhen Zhao
Yuzhen Zhao
CLChanghua Liu
Changhua Liu
JSJinjin Shi
Jinjin Shi

25 February 2025 in Supportive Care in Cancer
Verified
Journal Article
Closed access
HDHuili Deng
Huili Deng
TYTiantian Yang
Tiantian Yang
YHYuru Hu
Yuru Hu
JLJunjie Liu
Junjie Liu
HCHsiuLing Chou
HsiuLing Chou
QSQu Shen
Qu Shen